45% (32/71) of patients became MOG-antibody negative and in relapsing patients negative seroconversion was associated with a lower relapse risk (relative risk 0.11 95% CI 0.05 to 0.26; p<0.001). No ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback